SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ -- Lunit, a leading provider of AI for cancer diagnostics and precision oncology, today announced it will present 14 studies at the Radiological Society ...
5d
Science for living: Can using AI risk prediction in breast cancer screening improve early detection?
Artificial intelligence is transforming medicine, but what does that mean for breast cancer screening? Researchers at UMass Chan Medical School are exploring how an AI-based tool might help identify ...
Launched in 2023 and expanded nationally in 2024, the program combined Amalgam's clinical decision support and population health workflows with Exact Sciences' Cologuard® test as a noninvasive ...
One way cancer specialists detect the disease is by examining cells and bodily fluids under a microscope, a time-consuming ...
Tempus AI recently reported full-year 2025 results, with revenue rising to US$1.27 billion and net loss narrowing to US$245.03 million, alongside 83% year-over-year Q4 growth driven by diagnostics. At ...
Owkin Announces International Validation Results of BRCAura: AI-Driven Screening for gBRCA Mutations Directly From Pathology Slides Owkin shares promising validation results for BRCAura RUO, a ...
Zacks Investment Research on MSN
Tempus AI & Median partner to add AI lung cancer screening to Pixel
Tempus AI, Inc. TEM recently announced a collaboration with Median Technologies to integrate Median’s proprietary eyonis LCS solution into the Tempus Pixel platform. The integration is expected to ...
Tempus AI (NasdaqGS:TEM) has launched a new AI-driven HRD-RNA algorithm aimed at improving cancer diagnostics. The company has entered a partnership with Median Technologies to bring advanced lung ...
Tempus AI launched its HRD-RNA algorithm, an AI-driven model for identifying Homologous Recombination Deficiency in cancer patients. The company also partnered with Median Technologies to integrate ...
RadNet will now offer AI-driven services across screening, detection, interpretation and follow-up across multiple disease areas.
Researchers have developed an electronic nose that can “smell” early signs of ovarian cancer in the blood. The method is precise and could eventually be used to find many different cancers.
India Today on MSN
Goa's AI X-ray breakthrough is catching lung cancer before it kills
A state-led AI screening drive flags hidden tumours early and sparks national scale-up talks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results